Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank85
3Y CAGR-18.8%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
-18.8%/yr
Annual compound
Percentile
P85
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4.08M+118.8%
2024$-21.73M-1419.9%
2023$1.65M-78.4%
2022$7.62M-89.3%
2021$71.48M+177.0%
2020$-92.79M-16178.8%
2019$-570000.00+33.7%
2018$-860000.00+41.2%
2017$-1.46M-6.2%
2016$-1.38M-